[The pharmacological action of rubidium chloride in depression].

IF 0.7 Q3 Medicine

Minerva Psichiatrica Pub Date : 1996-03-01

A O Brundusino, S Cairoli

引用次数: 0

Abstract

In the last few years antidepressant activity or Rubidium chloride has risen new interest. The drugs develops his action on dopaminergic stimulation reducing the depressive pattern. Fifteen depressed inpatients were studied for three weeks treated with Rubidium chloride (540 mg/day) and periodically monitored after hospitalization. Speed therapeutic efficacy has been shown, with lack of side effects. The results are discussed.

本刊更多论文

[氯化铷治疗抑郁症的药理作用]。

近年来，氯化铷的抗抑郁活性引起了新的关注。该药物对多巴胺能产生刺激作用，减少抑郁模式。本研究对15例抑郁症住院患者进行为期3周的氯化铷治疗(540 mg/d)，并在住院后定期监测。治疗效果快，无副作用。对结果进行了讨论。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Minerva Psichiatrica PSYCHIATRY-

CiteScore

1.10

自引率

0.00%

发文量

期刊介绍： The journal Minerva Psichiatrica publishes scientific papers on psychiatry, psycology and psycopharmacology. Manuscripts may be submitted in the form of editorials, original articles, review articles, case reports, therapeutical notes, special articles and letters to the Editor. Manuscripts are expected to comply with the instructions to authors which conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Editors by the International Committee of Medical Journal Editors (www.icmje.org). Articles not conforming to international standards will not be considered for acceptance.